Differential [qlco]
effects [qlco]
Hormone replacement therapy [topp]
Endogenous [ftcn]
oxide [inch]
Nitrite [chvs]
Nitrate [chvs]
Level [qlco]
postmenopausal [tmco]
Women [popg]
valerate [lipd]
Cyproterone Acetate [phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
Increased [qnco]
Incidence [qnco]
Cardiovascular disease [dsyn]
postmenopausal [tmco]
Women [popg]
Ovarian dysfunction [dsyn]
Hormone replacement therapy [topp]
effects [qlco]
Hypertension [dsyn]
Atherosclerosis [dsyn]
Associated [qlco]
Impaired [ftcn]
Release [hlca]
Nitric Oxide, Endothelium-Derived [bacs, inch, phsu]
Increased [qnco]
Levels [qlco]
Low-Density Lipoproteins [aapp, bacs, lipd]
investigated [ftcn]
Hormone replacement therapy [topp]
augment [qnco]
Nitric Oxide [bacs, inch, phsu]
Release [hlca]
increases [ftcn]
Decrease [qlco]
Level [qlco]
postmenopausal [tmco]
Women [popg]
Serum [bdsu]
Nitrite [chvs]
Nitrate [chvs]
Level [qlco]
baseline [bodm]
Initiation [menp]
Hormone replacement therapy [topp]
months [tmco]
Study [mnob]
postmenopausal [tmco]
Women [popg]
N NOS [aapp, imft]
Received [qlco]
Continuous [idcn]
Administration, Oral [topp]
Oestradiol valerate [horm, phsu, strd]
Progynova [phsu, strd]
mg% [qnco]
Daily [tmco]
days [tmco]
Supplement [food]
Oral [spco]
Cyproterone Acetate [phsu, strd]
CPA [gngm]
mg% [qnco]
N NOS [aapp, imft]
medroxyprogesterone acetate [horm, phsu, strd]
mg% [qnco]
N NOS [aapp, imft]
days [tmco]
treatment [ftcn]
Cycle [tmco]
blood samples [bdsu]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Collected [idcn]
times [tmco]
Subject [grup]
Take [hlca]
Oestradiol valerate [horm, phsu, strd]
Alone [qnco]
Oestradiol valerate [horm, phsu, strd]
CPA [gngm]
Compared [acty]
Sample [sbst]
Collected [idcn]
baseline [bodm]
Serum [bdsu]
Levels [qlco]
Increased [qnco]
mU/L [qnco]
Mole [neop]
baseline [bodm]
mU/L [qnco]
Mole [neop]
P NOS [aapp, imft]
Sample [sbst]
Collected [idcn]
months [tmco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Not [ftcn]
Take [hlca]
Progestins [horm, phsu, strd]
CPA [gngm]
mU/L [qnco]
Mole [neop]
P NOS [aapp, imft]
Sample [sbst]
treatment [ftcn]
CPA [gngm]
included [ftcn]
Analysis [lbpr]
Increase [ftcn]
Serum [bdsu]
Levels [qlco]
Observed [ftcn]
Only [qnco]
postmenopausal [tmco]
Women [popg]
Oestradiol valerate [horm, phsu, strd]
Suggest [idcn]
Estradiol [horm, phsu, strd]
Endogenous [ftcn]
nitric oxide synthesis [moft]
Differential [qlco]
Compared [acty]
baseline [bodm]
increases [ftcn]
Serum [bdsu]
Observed [ftcn]
Sample [sbst]
Collected [idcn]
Estradiol [horm, phsu, strd]
treated [topp]
CPA [gngm]
serum LDL [lbpr]
Level [qlco]
Reduced [qlco]
Sample [sbst]
Collected [idcn]
months [tmco]
Hormone replacement therapy [topp]
P NOS [aapp, imft]
baseline [bodm]
Show [inpr]
Negative [qlco]
Correlation [qlco]
Levels [qlco]
R- [spco]
P NOS [aapp, imft]
Not [ftcn]
Result [ftcn]
Administration, Oral [topp]
Oestradiol valerate [horm, phsu, strd]
postmenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
increases [ftcn]
Circulating [ftcn]
Nitric Oxide [bacs, inch, phsu]
Level [qlco]
Effect [qlco]
Contribute [acty]
effects [qlco]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Addition [ftcn]
Data [idcn]
Suggest [idcn]
Not [ftcn]
Concomitant [tmco]
Administration [ocac]
Progestin [horm, phsu, strd]
Attenuate [acty]
effects [qlco]
Estrogen Replacement Therapy [topp]
Nitric Oxide [bacs, inch, phsu]
Release [hlca]
Data [idcn]
Evidence [ftcn]
postmenopausal [tmco]
Estrogen [horm, phsu, strd]
treatment [ftcn]
Improvement [cnce]
Endogenous [ftcn]
Nitric Oxide [bacs, inch, phsu]
Level [qlco]
Suggest [idcn]
Not [ftcn]
postmenopausal [tmco]
Women [popg]
profit [orgt]
properties [qlco]
Hormone replacement therapy [topp]
